Close

Relmada Therapeutics (RLMD) Receives U.S. Patent Related to REL-1017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI
6. LRCX
7. BIIB
8. F
9. CNMD
10. BSX


Go back to Relmada Therapeutics (RLMD) Receives U.S. Patent Related to REL-1017
(NASDAQ: RLMD) Delayed: 3.86 --0 (-0%)
Previous Close $3.86    52 Week High $4.10 
Open $3.86    52 Week Low $0.87 
Day High $3.86    P/E N/A 
Day Low $3.86    EPS $0.00 
Volume 9,542